Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
BJU International|March 24, 2018
Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)Giuseppe Morgia, Giuseppe Vespasiani, Rosaria M Pareo, et al.
The Prostate|August 27, 2014
Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial)Giuseppe Morgia, Giorgio I Russo, Salvatore Voce, et al.
Minerva Anestesiologica|April 3, 2019
Joint consensus on anesthesia in urologic and gynecologic robotic surgery: specific issues in management from a task force of the SIAARTI, SIGO, and SIUPaola Aceto, Luigi Beretta, Claudia Cariello, et al.
Frontiers in Urology|August 8, 2025
Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case-control prospective study (COMP study)Giuseppe Morgia, Arturo Lo Giudice, Sebastiano Cimino, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 8, 2015
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working GroupDomenico Prezioso, Pasquale Strazzullo, Tullio Lotti, et al.
BJU International|September 3, 2015
Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) studyGiuseppe Morgia, Giorgio Ivan Russo, Andrea Tubaro, et al.
Urology|July 13, 2016
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) StudyGiuseppe Morgia, Giorgio Ivan Russo, Andrea Tubaro, et al.
Pageof 6